INBX
INHIBRX BIOSCIENCES INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
INHIBRX BIOSCIENCES INC (INBX) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$128.80M; the largest are Andreas Halvorsen, Izzy Englander, Renaissance Technologies. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 1 added, 2 trimmed, 2 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders41 also report options
Congress trades0
Price$101.71vs quarter-end+7.35%
Sectors0
This quarter's moves
Top holderNew1
Added1
Trimmed / sold4
Andreas HalvorsenCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Value $106.49M0.3% of portfolio1,123,9292026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Andreas Halvorsen | $106.49M | 0.3% | Trim |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $3.53M— of portfolio37,3002026 Q2
Value $511.6K— of portfolio5,4002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $3.53M | — | — |
| Ken GriffinPUT | $511.6K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.